Alfredo Saavedra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alfredo Saavedra has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Edgar Alberto Sánchez
Universidad Nacional de Colombia, Hospital Universitario Nacional de Colombia, Neumología Clínica, Bogotá, Colombia
2 shared publications - María Angélica Moreno Carrillo
Universidad Nacional de Colombia
2 shared publications Ana Milena Callejas Gutierrez
Instituto Nacional de Cancerologia
1 shared publication- Aura Lucía Leal
Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá 111321, Colombia
1 shared publication - Carlos Arturo Álvarez-Moreno
Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá 111321, Colombia
1 shared publication - Carlos Humberto Saavedra
Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Medicina Interna - Bogotá D.C. - Colombia. | Hospital Universitario Nacional de Colombia - Proceso de Atención Hospitalaria - Bogotá D.C. - Colombia
1 shared publication
Latest Publications
- Open Access
- 3 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 37 (1) , 16-25
Utilidad de la broncoscopia flexible en pacientes con neoplasia hematológica atendidos en la unidad de tórax del Instituto Nacional de Cancerología
Introduction. Pulmonary complications are common in patients with hematologic neoplasms, occurring in up to 60% of cases, which can be of infectious or non-infectious origin, increasing morbidity and mortality. (1) (2). Previous studies have shown that bronchoalveolar lavage (BAL) and transbronchial or endobronchial biopsies can identify pathogens in a significant percentage of patients, facilitating adjustments to initial empirical treatment. (3) (4) . Despite advances in medical literature, there are still limitations in understanding the diagnostic utility of bronchoscopy in patients with hematologic neoplasms, especially in those already receiving empirical treatment. Additionally, there is a lack of consensus on the actual impact of bronchoscopy on treatment modification and its influence on clinical outcomes. Materials and Methods. A retrospective cohort study was conducted in patients over 18 years of age with hematologic neoplasms, treated in the thoracic service of the National Cancer Institute between January 2017 and April 2022. A total of 162 patients with a confirmed diagnosis of hematologic neoplasm requiring flexible bronchoscopy with bronchoalveolar lavage (BAL) and/or transbronchial/endobronchial biopsy were included, excluding those with contraindications such as severe oxygenation disorders, hemodynamic instability, or severe thrombocytopenia. Patients in intensive care were excluded due to lack of information on bronchoscopy results. Data were obtained from electronic medical records, and a validated collection instrument was used. Statistical analysis included measures of central tendency and dispersion for quantitative variables, and absolute and relative frequencies for qualitative variables. Diagnostic utility was defined as the proportion of patients whose treatment was modified following bronchoscopy. Results. Microbiological isolation was identified in 28% of cases, with Mycobacterium tuberculosis being the most frequent pathogen (20%), followed by Pseudomonas aeruginosa and Klebsiella pneumoniae (13% each). Histopathological findings were documented in 5% of cases, with non-Hodgkin lymphoma being the most frequent pathology. Bronchoalveolar lavage (BAL) was performed in 56.2% of cases, BAL + transbronchial biopsy in 34%, and BAL + endobronchial biopsy in 7.4%. Findings impacted treatment in 16% of patients (n=26). Conclusions: Bronchoscopy with BAL and/or transbronchial or endobronchial biopsy is a diagnostic tool whose utility varies depending on the type of disease, progression, and prior empirical treatment. In the current era of improved prophylaxis in these patients, bronchoscopy results may lead to only minimal changes in treatment.
- 3 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 37 (1) , 16-25
Open AccessUtilidad de la broncoscopia flexible en pacientes con neoplasia hematológica atendidos en la unidad de tórax del Instituto Nacional de Cancerología
Introduction. Pulmonary complications are common in patients with hematologic neoplasms, occurring in up to 60% of cases, which can be of infectious or non-infectious origin, increasing morbidity and mortality. (1) (2). Previous studies have shown that bronchoalveolar lavage (BAL) and transbronchial or endobronchial biopsies can identify pathogens in a significant percentage of patients, facilitating adjustments to initial empirical treatment. (3) (4) . Despite advances in medical literature, there are still limitations in understanding the diagnostic utility of bronchoscopy in patients with hematologic neoplasms, especially in those already receiving empirical treatment. Additionally, there is a lack of consensus on the actual impact of bronchoscopy on treatment modification and its influence on clinical outcomes. Materials and Methods. A retrospective cohort study was conducted in patients over 18 years of age with hematologic neoplasms, treated in the thoracic service of the National Cancer Institute between January 2017 and April 2022. A total of 162 patients with a confirmed diagnosis of hematologic neoplasm requiring flexible bronchoscopy with bronchoalveolar lavage (BAL) and/or transbronchial/endobronchial biopsy were included, excluding those with contraindications such as severe oxygenation disorders, hemodynamic instability, or severe thrombocytopenia. Patients in intensive care were excluded due to lack of information on bronchoscopy results. Data were obtained from electronic medical records, and a validated collection instrument was used. Statistical analysis included measures of central tendency and dispersion for quantitative variables, and absolute and relative frequencies for qualitative variables. Diagnostic utility was defined as the proportion of patients whose treatment was modified following bronchoscopy. Results. Microbiological isolation was identified in 28% of cases, with Mycobacterium tuberculosis being the most frequent pathogen (20%), followed by Pseudomonas aeruginosa and Klebsiella pneumoniae (13% each). Histopathological findings were documented in 5% of cases, with non-Hodgkin lymphoma being the most frequent pathology. Bronchoalveolar lavage (BAL) was performed in 56.2% of cases, BAL + transbronchial biopsy in 34%, and BAL + endobronchial biopsy in 7.4%. Findings impacted treatment in 16% of patients (n=26). Conclusions: Bronchoscopy with BAL and/or transbronchial or endobronchial biopsy is a diagnostic tool whose utility varies depending on the type of disease, progression, and prior empirical treatment. In the current era of improved prophylaxis in these patients, bronchoscopy results may lead to only minimal changes in treatment.
- Open Access
- 7 June 2024
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 36 (1) , 48-53
Leiomiomatosis pulmonar benigna metastatizante: una causa rara de nódulos pulmonares. Reporte de caso
Benign metastasizing leiomyomatosis (BML) is a rare condition, first described by Forkel in 1910, and at least 150 cases have been reported in the literature so far (1). It is caused by metastasis and proliferation of smooth muscle tissue from a uterine myoma. At the imaging level, it manifests with multiple nodules located most frequently in the lung, lymph nodes, peritoneum, bone, heart and skin. In symptomatic cases, they are usually taken to surgical resection, bilateral oophorectomy and/or hormonal inhibition, some cases being refractory. We present the case of a 51-year-old woman, who came for consultation due to a clinical picture of 2 years of evolution characterized by progressive dyspnea, associated with dry cough and chest pain. A history of hysterectomy for dysfunctional uterine bleeding 14 years ago was documented, and pathology report concluded a diagnosis of uterine leiomyomatosis. Chest CT scan revealed multiple non-calcified solid random pulmonary nodules. Samples obtained from the lung parenchyma were obtained by right thoracoscopy performing lateral segmental lobectomy of the middle lobe, with histopathological findings of mesenchymal proliferation, epithelial, and immunohistochemical markers compatible with metastatic leiomyomatosis.
- 7 June 2024
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 36 (1) , 48-53
Open AccessLeiomiomatosis pulmonar benigna metastatizante: una causa rara de nódulos pulmonares. Reporte de caso
Benign metastasizing leiomyomatosis (BML) is a rare condition, first described by Forkel in 1910, and at least 150 cases have been reported in the literature so far (1). It is caused by metastasis and proliferation of smooth muscle tissue from a uterine myoma. At the imaging level, it manifests with multiple nodules located most frequently in the lung, lymph nodes, peritoneum, bone, heart and skin. In symptomatic cases, they are usually taken to surgical resection, bilateral oophorectomy and/or hormonal inhibition, some cases being refractory. We present the case of a 51-year-old woman, who came for consultation due to a clinical picture of 2 years of evolution characterized by progressive dyspnea, associated with dry cough and chest pain. A history of hysterectomy for dysfunctional uterine bleeding 14 years ago was documented, and pathology report concluded a diagnosis of uterine leiomyomatosis. Chest CT scan revealed multiple non-calcified solid random pulmonary nodules. Samples obtained from the lung parenchyma were obtained by right thoracoscopy performing lateral segmental lobectomy of the middle lobe, with histopathological findings of mesenchymal proliferation, epithelial, and immunohistochemical markers compatible with metastatic leiomyomatosis.
- Open Access
- 1 March 2023
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 16 (1) , 59-66
Descripción de las intervenciones broncoscópicas en estenosis traqueales posterior a infección por COVID-19
Introduction: SARS-CoV-2 infection can lead to acute respiratory distress syndrome with a prolonged need for mechanical ventilation and delayed tracheostomy, resulting in an increase in cases of tracheal stenosis and the necessity for less invasive approaches. Methods: A descriptive cross-sectional study was conducted from March 2020 to December 2021 at the Hospital Universitario Nacional de Colombia, focusing on adults with post-intubation tracheal stenosis associated with SARS-CoV-2. Univariate analysis was performed between groups with or without SARS-CoV-2 infection as a control, considering reintervention, degree of stenosis, use of intratracheal steroids, or multiple stenoses as important outcomes. Fisher's exact test, Student's t-test, and Mann-Whitney test were employed based on the nature of variables. A p-value less than 0.05 was considered statistically significant. Results: A total of 26 patients were included, with 20 having COVID-19 and 6 without. Significant differences were found in age (p=0.002), epilepsy (p=0.007), and multiple stenosis (p=0.04). In 85% of cases, laser blue plus balloon pulmonary dilation was used, intratracheal dexamethasone in 35%, and reintervention in 35%, with no significant differences between groups. Conclusions: A threefold increase in subglottic stenosis was observed during the SARS-CoV-2 pandemic, with more instances of multiple stenosis and predominantly the use of laser blue plus balloon pulmonary dilation as a successful recanalization technique. There was a higher use of intratracheal dexamethasone in this group compared to other pathologies causing tracheal stenosis. Introducción: La infección por SARS-CoV-2 puede presentar síndrome de distrés respiratorio agudo con requerimiento de ventilación mecánica prolongada y retraso en la realización de traqueostomía. Esto trae como consecuencia un incremento en casos de estenosis traqueal y la necesidad de métodos menos invasivos para su abordaje. Métodos: Estudio descriptivo de corte transversal, desde marzo 2020 hasta diciembre 2021 en el Hospital Universitario Nacional de Colombia, en adultos con estenosis traqueal postintubación asociado SARS-CoV-2. Se realizó análisis univariado entre los grupos con infección o no por SARS-CoV-2 como control, y reintervención, grado de estenosis, uso de inyección intramucosa con dexametasona intratraqueal o múltiples estenosis como desenlaces de importancia. Se usó test exacto de Fisher, t Student y Man-Whitney según la naturaleza de variables. Se consideró p estadísticamente significativo menor a 0.05. Resultados: Se identificaron 26 pacientes, 20 tenían COVID-19 y 6 no. Se encontraron diferencias en edad (p=0,002), epilepsia (p=0,007) y estenosis múltiple (p= 0,04). En 85% de los casos se utilizó láser blue más dilatación con balón pulmonar, en 35% inyección intramucosa con dexametasona intratraqueal y reintervención en 35%, sin diferencias significativas entres grupos. Conclusiones: Se observó un incremento tres veces mayor de pacientes con estenosis múltiple en el grupo de infección por COVID-19, así mismo se encontró que el método más utilizado en este grupo para la recanalización fue el uso de láser blue más dilatación con balón pulmonar e inyección intramucosa con dexametasona intratraqueal.
- 1 March 2023
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 16 (1) , 59-66
Open AccessDescripción de las intervenciones broncoscópicas en estenosis traqueales posterior a infección por COVID-19
Introduction: SARS-CoV-2 infection can lead to acute respiratory distress syndrome with a prolonged need for mechanical ventilation and delayed tracheostomy, resulting in an increase in cases of tracheal stenosis and the necessity for less invasive approaches. Methods: A descriptive cross-sectional study was conducted from March 2020 to December 2021 at the Hospital Universitario Nacional de Colombia, focusing on adults with post-intubation tracheal stenosis associated with SARS-CoV-2. Univariate analysis was performed between groups with or without SARS-CoV-2 infection as a control, considering reintervention, degree of stenosis, use of intratracheal steroids, or multiple stenoses as important outcomes. Fisher's exact test, Student's t-test, and Mann-Whitney test were employed based on the nature of variables. A p-value less than 0.05 was considered statistically significant. Results: A total of 26 patients were included, with 20 having COVID-19 and 6 without. Significant differences were found in age (p=0.002), epilepsy (p=0.007), and multiple stenosis (p=0.04). In 85% of cases, laser blue plus balloon pulmonary dilation was used, intratracheal dexamethasone in 35%, and reintervention in 35%, with no significant differences between groups. Conclusions: A threefold increase in subglottic stenosis was observed during the SARS-CoV-2 pandemic, with more instances of multiple stenosis and predominantly the use of laser blue plus balloon pulmonary dilation as a successful recanalization technique. There was a higher use of intratracheal dexamethasone in this group compared to other pathologies causing tracheal stenosis. Introducción: La infección por SARS-CoV-2 puede presentar síndrome de distrés respiratorio agudo con requerimiento de ventilación mecánica prolongada y retraso en la realización de traqueostomía. Esto trae como consecuencia un incremento en casos de estenosis traqueal y la necesidad de métodos menos invasivos para su abordaje. Métodos: Estudio descriptivo de corte transversal, desde marzo 2020 hasta diciembre 2021 en el Hospital Universitario Nacional de Colombia, en adultos con estenosis traqueal postintubación asociado SARS-CoV-2. Se realizó análisis univariado entre los grupos con infección o no por SARS-CoV-2 como control, y reintervención, grado de estenosis, uso de inyección intramucosa con dexametasona intratraqueal o múltiples estenosis como desenlaces de importancia. Se usó test exacto de Fisher, t Student y Man-Whitney según la naturaleza de variables. Se consideró p estadísticamente significativo menor a 0.05. Resultados: Se identificaron 26 pacientes, 20 tenían COVID-19 y 6 no. Se encontraron diferencias en edad (p=0,002), epilepsia (p=0,007) y estenosis múltiple (p= 0,04). En 85% de los casos se utilizó láser blue más dilatación con balón pulmonar, en 35% inyección intramucosa con dexametasona intratraqueal y reintervención en 35%, sin diferencias significativas entres grupos. Conclusiones: Se observó un incremento tres veces mayor de pacientes con estenosis múltiple en el grupo de infección por COVID-19, así mismo se encontró que el método más utilizado en este grupo para la recanalización fue el uso de láser blue más dilatación con balón pulmonar e inyección intramucosa con dexametasona intratraqueal.
- Open Access
- 13 October 2021
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 33 (1) , 37-42
Fístula traqueoesofágica, a propósito de un caso
La fístula traqueoesofágica es una patología infrecuente que en general se asocia con patología tumoral esofágica y algunas veces con tumores primarios de vía aérea, que implican pobre sobrevida y mal pronóstico a corto plazo. El tratamiento requiere un enfoque multidisciplinario, se considera la colocación de endoprótesis como manejo de primera línea para alivio de síntomas y mejoría de calidad de vida. El artículo reporta el caso de un paciente con carcinoma escamocelular de tercio medio del esófago inoperable, con colocación exitosa de doble stent esofágico y traqueal.
- 13 October 2021
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 33 (1) , 37-42
Open AccessFístula traqueoesofágica, a propósito de un caso
La fístula traqueoesofágica es una patología infrecuente que en general se asocia con patología tumoral esofágica y algunas veces con tumores primarios de vía aérea, que implican pobre sobrevida y mal pronóstico a corto plazo. El tratamiento requiere un enfoque multidisciplinario, se considera la colocación de endoprótesis como manejo de primera línea para alivio de síntomas y mejoría de calidad de vida. El artículo reporta el caso de un paciente con carcinoma escamocelular de tercio medio del esófago inoperable, con colocación exitosa de doble stent esofágico y traqueal.
- Open Access
- 19 April 2021
- Published by Universidad Nacional de Colombia in Revista de la Facultad de Medicina
- Vol. 70 (2) , e93814
Guía de práctica clínica para el manejo de la neumonía adquirida en la comunidad
La neumonía sigue siendo una de las principales causas de consulta y de hospitalización a la que, además de su un alto impacto en términos de morbilidad y mortalidad, se suma la actual problemática de resistencia a los antimicrobianos, por lo que establecer directrices que permitan su adecuado diagnóstico y tratamiento es de gran importancia para obtener mejores desenlaces clínicos y promover un uso racional de antibióticos en estos pacientes. La presente guía de práctica clínica (GPC) contiene recomendaciones basadas en la evidencia para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad en adultos, las cuales fueron realizadas mediante el proceso de adaptación de GPC basadas en la evidencia para el contexto colombiano.
- 19 April 2021
- Published by Universidad Nacional de Colombia in Revista de la Facultad de Medicina
- Vol. 70 (2) , e93814
Open AccessGuía de práctica clínica para el manejo de la neumonía adquirida en la comunidad
La neumonía sigue siendo una de las principales causas de consulta y de hospitalización a la que, además de su un alto impacto en términos de morbilidad y mortalidad, se suma la actual problemática de resistencia a los antimicrobianos, por lo que establecer directrices que permitan su adecuado diagnóstico y tratamiento es de gran importancia para obtener mejores desenlaces clínicos y promover un uso racional de antibióticos en estos pacientes. La presente guía de práctica clínica (GPC) contiene recomendaciones basadas en la evidencia para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad en adultos, las cuales fueron realizadas mediante el proceso de adaptación de GPC basadas en la evidencia para el contexto colombiano.